These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 26185753

  • 1. The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population.
    Vázquez-Del Mercado M, Guzmán-Ornelas MO, Corona Meraz FI, Ríos-Ibarra CP, Reyes-Serratos EA, Castro-Albarran J, Ruíz-Quezada SL, Navarro-Hernández RE.
    Biomed Res Int; 2015; 2015():285491. PubMed ID: 26185753
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B.
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [Abstract] [Full Text] [Related]

  • 3. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM, Weisnagel SJ, Vohl MC, Rankinen T, Bouchard C, Pérusse L.
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41).
    Gayathri SB, Radha V, Vimaleswaran KS, Mohan V.
    Metab Syndr Relat Disord; 2010 Apr; 8(2):119-26. PubMed ID: 19900151
    [Abstract] [Full Text] [Related]

  • 6. The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients.
    Rodrigues APDS, Rosa LPS, da Silva HD, Silveira-Lacerda EP, Silveira EA.
    J Obes; 2018 Apr; 2018():2743081. PubMed ID: 30652031
    [Abstract] [Full Text] [Related]

  • 7. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians.
    Bhatt SP, Misra A, Sharma M, Luthra K, Guleria R, Pandey RM, Vikram NK.
    Diabetes Technol Ther; 2012 Sep; 14(9):828-34. PubMed ID: 22694222
    [Abstract] [Full Text] [Related]

  • 8. Analysis of candidate genes in Polish families with obesity.
    Malczewska-Malec M, Wybranska I, Leszczynska-Golabek I, Partyka L, Hartwich J, Jabrocka A, Kiec-Wilk B, Kwasniak M, Motyka M, Dembinska-Kiec A.
    Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
    Kruzliak P, Haley AP, Starcevic JN, Gaspar L, Petrovic D.
    Cardiovasc Diabetol; 2015 Apr 28; 14():42. PubMed ID: 25928419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.
    Guzmán-Ornelas MO, Petri MH, Vázquez-Del Mercado M, Chavarría-Ávila E, Corona-Meraz FI, Ruíz-Quezada SL, Madrigal-Ruíz PM, Castro-Albarrán J, Sandoval-García F, Navarro-Hernández RE.
    J Diabetes Res; 2016 Apr 28; 2016():5675739. PubMed ID: 26839895
    [Abstract] [Full Text] [Related]

  • 14. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
    Andrulionytè L, Zacharova J, Chiasson JL, Laakso M, STOP-NIDDM Study Group.
    Diabetologia; 2004 Dec 28; 47(12):2176-84. PubMed ID: 15592662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans.
    Myles S, Lea RA, Ohashi J, Chambers GK, Weiss JG, Hardouin E, Engelken J, Macartney-Coxson DP, Eccles DA, Naka I, Kimura R, Inaoka T, Matsumura Y, Stoneking M.
    BMC Med Genet; 2011 Jan 18; 12():10. PubMed ID: 21244673
    [Abstract] [Full Text] [Related]

  • 17. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L, Peltola P, Chiasson JL, Laakso M, STOP-NIDDM Study Group.
    Diabetes; 2006 Jul 18; 55(7):2148-52. PubMed ID: 16804087
    [Abstract] [Full Text] [Related]

  • 18. Genetic Background, Adipocytokines, and Metabolic Disorders in Postmenopausal Overweight and Obese Women.
    Grygiel-Górniak B, Kaczmarek E, Mosor M, Przysławski J, Bogacz A.
    Biochem Genet; 2016 Oct 18; 54(5):636-52. PubMed ID: 27246401
    [Abstract] [Full Text] [Related]

  • 19. Genetic susceptibility to pre diabetes mellitus and related association with obesity and physical fitness components in Mexican-Mestizos.
    Costa-Urrutia P, Abud C, Franco-Trecu V, Colistro V, Rodríguez-Arellano ME, Granados J, Seelaender M.
    Prim Care Diabetes; 2018 Oct 18; 12(5):416-424. PubMed ID: 30041843
    [Abstract] [Full Text] [Related]

  • 20. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
    Weng SW, Lin TK, Wang PW, Chen IY, Lee HC, Chen SD, Chuang YC, Liou CW.
    Metabolism; 2010 Apr 18; 59(4):581-6. PubMed ID: 19913841
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.